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Autoimmune responseBax Inhibitor-1 (BI-1) is an evolutionally conserved apoptotic suppressor and belongs to the BI-1 family
of proteins, which contain BI-1-like transmembrane domains. As their cellular functions and regulatory
mechanisms remain incompletely understood, we compared their anti-apoptotic properties. Forced expression
of BI-1 resulted in the most effective suppression of stress-induced apoptosis, compared with other family
members, together with signiﬁcant extracellular signal-regulated kinase (ERK)1/2 activation. BI-1-mediated
ERK1/2 activation led to the suppression of mitochondria-mediated reactive oxygen species (ROS) production.
Involvement of the ERK signaling pathway in BI-1-induced anti-apoptotic effects was conﬁrmed by knockdown
studies with ERK- or BI-1-speciﬁc siRNA. Moreover, we produced transgenic (TG)mice overexpressing BI-1, and
the relationship between ERK1/2 activation and the suppression of ROS production or apoptosis was conﬁrmed
in mouse embryonic ﬁbroblast (MEF) cells derived from these mice. Interestingly, we found that BI-1 TG mice
showed splenomegaly and abnormal megakaryopoiesis. Taken together, our results suggest that BI-1-induced
ERK1/2 activation plays an important role in the modulation of intracellular ROS generation and apoptotic cell
death and may also affect autoimmune response.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a necessary process for the control of cell growth
and elimination of damaged or unwanted cells, and its dysregulation
has been implicated in many diseases, including neurodegenerative
diseases and several types of cancer [1,2]. The fundamental process
of apoptosis is conserved in different species, including yeasts, worms,
mice, and humans [3]. Many studies have shown that all of these
organisms share similar apoptosis-regulating proteins and that the
apoptotic process proceeds through 2 main pathways, the cytoplasmic
and mitochondrial pathways. Both of these pathways are regulated by
several signaling proteins, including the B-cell lymphoma 2 (Bcl-2)
family proteins, kinases, and caspases [1].
Themitogen-activated protein kinase (MAPK) pathway, an important
apoptosis-regulating pathway, has been shown to regulate apoptosis
induced by UV irradiation, tumor necrosis factor (TNF), or TNF receptortechnolgy, Konkuk University,
+82 2 455 1044.
l rights reserved.superfamily member 6 (Fas) ligation [4]. MAPKs contain p42/p44
extracellular signal-related kinase (ERK), c-Jun N-terminal protein
kinase (JNK)/stress-activated protein kinase (SAPK), and p38 MAPK.
Several isoforms of MAPK have been characterized in mammals:
ERK1/2, 3/4, 5, and 7/8; JNK1, 2, and 3; and p38-α, -β, -γ, and -δ [5,6].
Each MAPK has been identiﬁed for its action in independent signaling
pathways leading to pleiotropic functions [7]. These proteins are
involved in the regulation of various biological processes, including
mitosis, proliferation, differentiation, and apoptosis [8,9]. Although
the mechanism of MAPK regulation of apoptosis varies with cell and
tissue type, generally, activation of JNK/SAPK and p38 MAPKs leads
to induction of apoptosis, whereas p42/44 ERK activity is associated
with suppression of apoptosis [7]. The anti-apoptotic effect of ERK1/2
can be regulated by a cascade comprised of the Ras/Raf/MEK (MAPK/
ERK kinase) 1/2/ERK1/2 pathways [8,9].
Bax inhibitor-1 (BI-1), also known as TEGT (testis enhanced gene
transcript), is an anti-apoptotic protein, which has been reported to
suppress cell death induced by Bax expression or other diverse stress
stimuli [10,11]. Its anti-apoptotic function is widely conserved in most
eukaryotes, including yeasts and plants, and even in prokaryotes
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the reduction of calcium content in the endoplasmic reticulum (ER),
ischemia–reperfusion injury, and ROS accumulation following ER
stress [19–21]. Analysis of the amino acid sequence of BI-1 has led
to the suggestion that BI-1 is an intracellular membrane protein con-
taining 6 or 7 transmembrane domains, and that these types of in-
tracellular membrane protein may have very important signaling and
transport functions [22,23]. As a large number of disease-related muta-
tions have been found in intracellular membrane proteins and are
reported to affect their stability, folding, and recognition in the mem-
brane bilayer, intracellular membrane proteins, including BI-1, may be
important targets for therapeutic applications [24,25].
Here, we studied the anti-apoptotic effects of several BI-1 family
proteins containing BI-1-like transmembrane domains and attempted
to reveal the molecular mechanism of BI-1-mediated anti-apoptosis
using cells and transgenic (TG) mice overexpressing BI-1.
2. Materials and methods
2.1. Antibodies and materials
Chemicals including etoposide, 2′, 7′-dichlorodihydroﬂuorescein
diacetate (H2-DCFDA), and N-acetylcysteine were purchased from
BioMOL (Plymouth Meeting, PA) and electrophoresis reagents
and protein assay kits were from Bio-Rad (Hercules, CA). The primary
antibodies used included those against hemagglutinin (HA, Cat.
No. SC-805), green ﬂuorescence protein (GFP, Cat. No. SC-8334),
actin (Cat. No. SC-8432), cytochrome C (Cat. No. SC-13156),
voltage-dependent anion channel (VDAC, Cat. No. SC-8828), ERK
(Cat. No. SC-153), JNK (Cat No. SC-7345), p38 (Cat. No. SC-7149),
phospho-JNK (Cat. No. SC-6254), and poly (ADP-ribose) polymerase
(PARP, Cat. No. SC-7148) (Santa Cruz Biotechnology, Santa Cruz, CA),
and phospho-p38 (Cat. No. 9211S), and phospho-ERK (Cat. No. 9106S)
(Cell Signaling, Danvers, MA).
2.2. Analysis of the amino acid sequences of BI-1 family proteins
Amino acid sequences of BI-1 family proteins were retrieved from
GenBank (NCBI). Accession numbers of the protein sequences are as
follows: TMBIM4 (transmembrane Bax inhibitor motif containing 4:
NP_057140.1), FAIM2 (Fas apoptotic inhibitory molecule 2:
NP_036438.2), GHITM (growth hormone-inducible transmembrane
protein: NP_055209.2), and BI-1 (Bax inhibitor-1: NP_003208.1).
The degree of sequence identity was determined using expected
value calculation based on the GenBank division. Multiple sequence
alignment was performed using the ClustalW program, and the
SMART domain analysis program (http://smart.embl-heidelberg.de/)
was used for prediction of the domain architecture of BI-1 family pro-
teins. ScanProsite (http:www.expasy.org/tools/scanprosite/PROSITE)
and NCBI RPS-BLAST (http://www.ncbi.nlm.nih.gov/Structure/cdd/
wrpsb.cgi) were used for conserved domain database screening.
2.3. Plasmid construction
BI-1 family genes were ampliﬁed by PCR using human fetal
brain cDNA (BD Biosciences, Franklin Lakes, NJ) and the following
primers: BI-1 (F) (5′-GGGAAGAATTCATGAACATATTTGATCGA-3′),
BI-1 (R) (5′-GGGAACTCGAGTCATTTCTTCTCTTTCTT-3′), GHITM (F)
(5′-ATGTTGGCTGCAAGG CTG-3′), GHITM (R) (5′-TGATCCCATTAACTC-
GATGCTGA-3′), FAIM2 (F) (5′-ATGACCCAGGGAA A-3′), FAIM2 (R)
(5′-CACTAACCGAGAATGA-3′), TMBIM4 (F) (5′-ATGTGGTCGAGTGTA-3′),
and TMBIM4 (R) (5′-GTTAATAAAAAGTAA-3′). The PCR products
were digested with EcoRI/XhoI, subcloned into pDS-GFP, and the
plasmid sequence was then conﬁrmed by DNA sequencing. Using
PCR-based methods, a mutant form (BI-1 ΔC) of BI-1 was generated
by deletion of the last 9 amino acids at the protein's C-terminal region.Primers for C-terminal truncation of BI-1 included 5′-GGGAAGAATT-
CATGAACATATTTGATCGA-3′ and 5′-GGGAACTCGAGTCACTAGGACCGG
TACT TA-3′. DNA fragments containing BI-1 or BI-1 ΔC were subcloned
into a pEF mammalian expression vector containing an oligonucleotide
encoding an HA tag upstream of BI-1 and BI-1 ΔC. For RNA interference
of BI-1 expression, a double-stranded oligonucleotide was designed
according to a common BI-1 sequence (Target sequence: 5′-CCCCGU-
CAACGCAGCAGCA-3′ as previously described [26]) to allow formation
of the hairpin structure in the expressed oligo-RNA. This was then
cloned into the pSilencer vector from Ambion (Austin, TX). ERK-1 and
2 speciﬁc siRNAs (Cat. No. sc-29308) and control siRNA purchased
from Santa Cruz were used for RNA interference of ERK expression,
according to the manufacturer's protocol.2.4. Reverse transcriptase PCR (RT-PCR)
Total RNA was isolated from different tissues using TRIzol from
Invitrogen (Carlsbad, CA) according to the manufacturer's instructions.
The ﬁrst-strand cDNA was prepared from 2ug of total RNA isolated
using reverse transcriptase with oligo-dT primer. cDNA was subjected
to PCR ampliﬁcation with DNA primers selective for genes. PCR
was carried out using Hot-start Taq polymerase (Finnzymes, Espo,
Finland), as follows; for an initial denaturation step at 95 °C for
15 min, followed by 35 ampliﬁcation cycles at 95 °C for 30 s, 51–59 °C
for 30 s and 72 °C for 30 s, and a ﬁnal step at 72 °C for 5 min. All samples
were run in triplicate. Primer sequences were as follows: TMBIM4 [F]:
5′-CATCCGAATGGCCTTTCTG-3′, TMBIM4 [R]: 5′-GTAGGTACAGGTT-
AAGGGG-3′; FAIM2 [F]: 5′-GTACTGGGCATCCTATGCT-3′, FAIM2 [R]:
5′-GTACTGGGCATCCTATGCT-3′; GHITM [F]: 5′-CAAGAATTGGGATCC-
GGCG-3′, GHITM [R]: 5′-CCTTGACATACTGAGGCC-3′; BI-1 [F]: 5′-
GCAGGGGCCTATGTCCAT-3′, BI-1 [R]: 5′-AGGATGCTGGGGTTGACAGC-
3′; GFP-exo [F]: 5′-CTGAGCAAAGACCCCAACG-3′. The integrity of each
RNA sample was checked by RT-PCR with mouse glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) primers (GAPDH [F]: 5′-AGAA-
CATCATCCCTGCATCC-3′, GAPDH [R]: 5′-CACCACCTTCTTGATGTC-3′) as
an internal standard.2.5. Cell culture and DNA transfection
Human embryonic kidney (HEK) 293 cells were cultured at 37 °C in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with 10%
fetal bovine serum (FBS; Hyclone, Logan, UT) and 100 U/ml penicillin/
100 μg/ml streptomycin (P/S). For DNA transfection, HEK 293 cells
were incubated overnight at a density of 3×106 cells per 100-mm
culture dish and transfected with the expression vectors indicated
using Lipofectamine (Invitrogen). For selection of HEK 293 cells that
stably expressed BI-1 or BI-1 ΔC, cells were transfected with 6 μg
pEF HA (control), pEF HA-BI-1, or BI-1 ΔC and treated with G418
(200 μg/ml) 24 h after transfection. After selection with G418, the
surviving HEK 293 cells were analyzed by RT-PCR and western
blotting.2.6. Determination of cell viability
Cells were plated at a density of 5×104 cells in 96-well plates and
cell viability was evaluated via a conventional 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Brieﬂy,
after incubation, the cellswere treatedwithMTT solution (ﬁnal concen-
tration, 0.25 mg/ml) for 4 h at 37 °C. Dark blue formazan crystals that
formed in the intact cells were dissolved with DMSO and absorbance
was then measured at 570 nm using an ELISA reader (BD Biosciences).
Results were expressed as a percentage of MTT reduction, and absor-
bance exhibited by the control cells was arbitrarily set as 100%.
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Cells were collected by centrifugation, washed once with cold PBS,
ﬁxed in ice-cold methanol/acetic acid (1:1, v/v) for 5 min, and then
stained with 0.8 mg/ml of 4′,6-diamidino-2-phenolindole (DAPI) in
the dark. Morphological changes in apoptotic cells were assessed vi-
sually under a Zeiss Axiovert 200 microscope from Carl Zeiss (Jena,
Germany) in the region of DAPI ﬂuorescence (excitation, 351 nm;
emission, 380 nm).
2.8. Determination of mitochondrial membrane potential
Cells were collected after exposure to 30 μM etoposide for 24 h.
They were washed and resuspended in 1 ml PBS containing 2 μM
DiOC6 and incubated at 37 °C in the dark for 15 min. Mitochondrial
membrane potential (Δψm) was assessed using a FACSCalibur ﬂow
cytometer from BD Biosciences.
2.9. Subcellular fractionation
Cells were harvested in an isotonic mitochondrial buffer (210 mM
mannitol, 70 mM sucrose, 1 mM EDTA, and 10 mM HEPES, pH 7.5)
supplemented with the protease inhibitor cocktail Complete (Roche,
Mannheim, Germany) and homogenized for 30–40 strokes using a
Dounce homogenizer. To eliminate nuclei and unbroken cells, samples
were centrifuged at 500×g for 5 min at 4 °C. The supernatant was
removed and centrifuged at 10,000×g for 30 min at 4 °C to obtain a
heavy membrane pellet enriched with mitochondria and the resulting
supernatant was stored as the cytosolic fraction.
2.10. Western blot analysis
Cells in 60-mm dishes were washed 3 times in ice-cold PBS,
scraped from the dishes, and collected in extraction buffer (1% Triton
X-100, 100 mMTris–HCl, p 7.5, 10 mMNaCl, 10% glycerol, 50 mMsodium
ﬂuoride, and 1 mMphenylmethylsulfonyl ﬂuoride [PMSF]). After the cells
had been incubated on ice for 30 min, the lysates were centrifuged and
the amount of protein in the cleared lysates was quantiﬁed using the
Bradford Protein Assay Reagent (Bio-Rad). Equal amounts of protein
were separated on 10%–12% SDS PAGE gels and transferred electropho-
retically onto nitrocellulose membranes (0.2 mm). These membranes
were blocked with 3%–5% non-fat dry milk and Tris-buffered saline
(TBS) and subsequently probed with primary antibody in TBS containing
3% non-fat dry milk. Antibody–antigen complexes were detected using
goat anti-mouse IgG or goat anti-rabbit IgG peroxidase conjugates,
followed by use of an enhanced chemiluminescence (ECL) detection
kit from Amersham (Buckinghamshire, UK).
2.11. Detection of intracellular ROS production
For measurement of intracellular ROS levels, cells were incubated
with 10 μM H2-DCFDA for 30 min at 37 °C in the dark, washed, and
suspended in PBS. Fluorescence-stained cells were imaged on an
inverted ﬂuorescence microscope and analyzed with a FACSCalibur
ﬂow cytometer using CellQuest 3.2 software for acquisition and
analysis.
2.12. Immunoﬂuorescence analysis
The cells were treated with MitoTracker red dye (Invitrogen,
25 nM) for 15 min in an incubator (37 °C, 5% CO2), washed three
times with PBS, ﬁxed for 15 min with 4% cold paraformaldehyde
and rinsed three times with PBS. Cells were incubated for 1 h with
5% normal goat serum (Vector Laboratories, Burlingame, CA) to
block nonspeciﬁc staining, followed by incubation with anti-HA
antibodies overnight at 4 °C. After washing with PBS, cells wereincubated for 1 h with ﬂuorescein isothiocyanate (FITC)-conjugated
secondary antibody (1:200). Immunoﬂuorescent images were ana-
lyzed using confocal microscopy (Nikon C1 laser scanning confocal
microscope).2.13. Generation of BI-1 TG mice
The standard microinjection procedure was used for the production
of TGmice (Macrogen, Seoul, Korea). Brieﬂy, fertilizedmouse eggswere
ﬂushed from the oviducts of superovulated C57BL/6NCrjBgi mice and
male pronuclei were injected with pEF HA/BI-1 DNA (2 ng/μl) that
had been linearized with PI–SceI at its cognate restriction site located
in the pEF HA vector. The injected eggs were reimplanted in the
oviducts of pseudo-pregnant imprint control region (ICR) recipient
females. At 3 weeks of age, the animals were tested for the presence
of the transgene by PCR analysis of their genomic DNA. For genomic
DNA-PCR analysis, primer pairs containing the BI-1 coding sequence
(BI-1 [R]: 5′-CATGAAAGCAGTGGGAAGGATG-3′) were used together
with the elongation factor (EF) promoter sequence (promoter [F]:
5′-GATGGAGTTTCCCCACACTGA-3′).2.14. Isolation and culture of mouse embryonic ﬁbroblast (MEF) or
splenocyte cells
In order to isolate MEFs, 14 day-7 embryos from control and BI-1
TG mice were used as previously described [27]. Brieﬂy, placental
membranes, amniotic sac, head, and primordial blood organs were
removed. The remaining carcass was washed and minced in 2 ml
PBS using a syringe and an 18-gauge needle, passed through a 100-μm
strainer for removal of large fragments, and placed in a 60-mm dish
containing DMEM, 10% FBS, 100 U/ml penicillin, and 100 μg/ml strepto-
mycin.MEF culture used for each experimentwas derived from a single
embryo. Cells were passaged at 106 per 100 mm dish when they
reached ~80% conﬂuence. Spleens were surgically removed and kept
on ice in sterile DMEM supplemented with 1% FBS. Bulk cultures were
established in DMEM supplemented with 10% FBS, 2 mM L-glutamine,
and 100 U/ml P/S.2.15. Histological analysis
Dissected spleen from control or BI-1 TG mice was ﬁxed in 4%
paraformaldehyde overnight at 4 °C, washed, and stored in 70% ethanol
until ready for processing for parafﬁn embedding. Embedded tissuewas
sectioned (thickness, 5 μm) on a Jung RM 2025 microtome from Leica.
For histological examination, the slides were stained with hematoxylin
and eosin (H&E) according to the standard protocols. For immunohisto-
chemistry, sections were then incubated with the respective antibodies
in 0.5% blocking buffer (normal goat serum). Sectionswere washed and
incubated with anti-mouse secondary antibodies (Oncogene Research
Products, San Diego, CA) diluted 1:1000 in 0.5% blocking buffer for
1 h at room temperature. Vectastain Elite ABC and diaminobenzidine
(DAB) substrate kits were used to detect immuno-peroxidase staining
according to the manufacturer's instructions (Vector Laboratories,
Burlingame, CA).2.16. Statistical analysis
All values are expressed as the mean±SE. Each value is the mean of
at least 3 independent experiments in eachgroup. Statistical signiﬁcance
of the differences between the 2 cell populations was determined using
the two-tailed Student's t-test (Origin) and P values equal to or less than
0.05 were considered signiﬁcant.
Fig. 1. Bioinformatic analysis revealed BI-1 family proteins. (A) Amino acid alignment of BI-1 family proteins was conducted. Protein sequences of TMBIM4, FAIM2, GHITM, and BI-1
were aligned using ClustalW. Identical amino acids highlighted in black and gray indicate conservative changes. (B) Phylogenetic tree analysis was carried out for selected members
of the BI-1 family of proteins. The tree was derived from neighbor-joining distance analysis using MEGA4. (C) Protein domain and topology prediction was conducted for BI-1 family
proteins. UPF0005 (uncharacterized protein family 0005) domain and transmembrane architecture of BI-1 family proteins were derived from TMHMM, TMPRED, and SMART
domain analysis.
879J.-H. Kim et al. / Biochimica et Biophysica Acta 1823 (2012) 876–888
Fig. 2. BI-1 displayed effective protection against etoposide-induced apoptosis. (A) An expression assay was performed for BI-1 family proteins. HEK 293 cells were transiently
transfected with pDS-GFP-GHITM, pDS-GFP-TMBIM4, pDS-GFP-FAIM2, pDS-GFP-BI-1, or control vector using Lipofectamine. Using speciﬁc primers (BI: BI-1, FA: FAIM2, TM4:
TMBIM4, GH: GHITM), RT-PCR analysis demonstrated endogenous or exogenous BI-1 family mRNA levels in each transfectant. Expression of the speciﬁc proteins was checked
via western blot analysis with GFP antibody. Actin was used as a loading control. (B, C) Cell viability and apoptotic cell rates were measured using the MTT assay and DAPI staining
analysis. Following transfection for 24 h with each vector, cells were treated with or without etoposide (7.5, 15, and 30 μM) for a further 48 h. All data are expressed as the means±
SE of values obtained in 5 separate experiments. (D) Following treatment of transfectant cells with or without etoposide (30 μM) for 0, 24, or 48 h, whole cell extracts were
analyzed for PARP cleavage with a speciﬁc polyclonal antibody.
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3.1. Overexpression of BI-1 family proteins shows an anti-apoptotic effect
on stress-induced cell death
From the NCBI sequence database we retrieved amino acid se-
quences for members of the BI-1 family proteins, such as TMBIM4,
FAIM2, and GHITM. Comparison of the primary structure of BI-1
and other BI-1 family proteins revealed 32% identity with TMBIM4,
31% identity with GHITM, and 25% identity with FAIM2, but no sig-
niﬁcant identity with GRINA (glutamate receptor, ionotropic, N-
methyl D-aspartate-associated protein 1) and TMBI1 (transmem-
brane Bax inhibitor motif containing 1) (Fig. 1). Homologous BI-1
family proteins were aligned using a multiple sequence alignment
tool (ClustalW) and we determined that the hydrophobic and
polar residues were preserved in speciﬁc positions (Fig. 1A). Based
on the sequences of BI-1 family proteins, a phylogenetic tree was
constructed by the maximum likelihood method using MEGA4from a base tree calculated by the neighbor-joining method using
ClustalW (Fig. 1B). In the phylogenetic tree, these family proteins
were closely related and the relationship between family proteins
was paralogous. All of the proteins were analyzed to determine
whether or not they contained conserved hydrophobic transmem-
brane domains known as UPF0005 (uncharacterized protein family
0005); however, they were expected to have slightly different trans-
membrane domain structures (Fig. 1C). We found that GFP-tagged
BI-1 family genes, such as FAIM2, TMBIM4, and GHITM had similar
expression levels in the respective transfected HEK 293 cells and
tested the ability of BI-1 family proteins to suppress stress-
induced apoptosis (Fig. 2A). Although all of the BI-1 family pro-
teins showed a suppressive effect on etoposide-induced cell
death, overexpression of BI-1 showed the most signiﬁcant anti-
apoptotic reaction in HEK293 cells (Fig. 2B and C). Next, we
checked PARP cleavage after etoposide treatment and found that
overexpression of BI-1 could signiﬁcantly block stress-induced PARP
cleavage (Fig. 2D).
Fig. 3. BI-1 overexpression led to prevention of mitochondria-mediated-apoptosis and ROS production in etoposide treated cells; however, BI-1 ΔC overexpression did not. (A) The
construct of the deletion mutant of BI-1 (BI-1 ΔC) is shown in the left panel. Expression of HA/BI-1 or HA/BI-1 ΔC was conﬁrmed via RT-PCR using HA/BI-1 primers and western blot
analysis with HA antibody as a control, BI-1, or BI-1ΔC cells (right panel). Actinwas used as a loading control. (B) Cell viability wasmeasuredwith theMTT assay. Stable transfectant cells
were treatedwith etoposide (7.5, 15, or 30 μM) for 48 h. (C) Apoptotic cells were assessed by DAPI staining. Control, BI-1, or BI-1ΔC cells were treatedwith orwithout etoposide (7.5, 15,
or 30 μM) for 48 h. Cells with apoptotic nuclear morphology were counted via ﬂuorescence microscopy after DAPI staining. Results represent the means±SE of values obtained from 3
separate experiments. (D)Mitochondrial membrane depolarizationwas quantiﬁed byDiOC6 staining and subsequent FACS analysis. The cells were incubated in 30 μMetoposide for 24 h,
then stained with 2 μM DiOC6, and analyzed by FACScan. (E) Following treatment with 30 μM etoposide for 24 h, samples were harvested in isotonic mitochondrial buffer and homog-
enized. As described in the Materials and methods section, supernatant and mitochondrial pellets corresponding to 30 μg mitochondrial proteins were analyzed by western blotting.
(F) Following treatment with 30 μM etoposide for 36 h, cells were stained with the ﬂuorescent probe H2-DCFDA (10 μM), and intracellular ROS levels were measured by ﬂuorescence
microscopy or ﬂow cytometry. Increased ROS level was indicated by an increase in ﬂuorescence. All data are expressed as the means±SE of values obtained in 3 separate experiments.
(G) Immunoﬂuorescence of HEK 293 cells transfected with plasmids containing GFP- or HA-tagged BI-1 and BI-1 ΔC. The green channel shows the ﬂuorescence of GFP or HA fusion
proteins and the red channel shows the ﬂuorescence of the MitoTracker indicating the subcellular patterns of mitochondria.
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apoptosis
We prepared BI-1 ΔC, which was known to be an inactive mutant
form of BI-1 [11,28,29], by deleting 9 amino acids (EKDKKKEKK) atthe C-terminal region, downstream of the UPF domain of BI-1 and
tested the effect of expression of BI-1 or BI-1 ΔC on apoptotic cell
death (Fig. 3A). Compared with the control cells, BI-1-expressing
cells showed signiﬁcantly greater resistance to etoposide-induced
cell death, along with a signiﬁcant increase in cell viability, but BI-1
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fragmentation was apparently reduced by BI-1 overexpression, but
not by BI-1 ΔC overexpression (Fig. 3C). Next, we examined the effects
of BI-1 overexpression on both loss of mitochondrial membrane
potential (Δψm) and release of cytochrome C. Triggering apoptosis
with etoposide led to perturbation of the mitochondrial membrane
potential in control and BI-1 ΔC cells, whereas BI-1 overexpression
apparently suppressed the decrease in mitochondrial potential
(Fig. 3D). The release of mitochondrial cytochrome C following
etoposide stimulation was also inhibited by BI-1 overexpression,
but not by BI-1 ΔC expression (Fig. 3E). The purity of the cytosolic
and mitochondrial fractions was conﬁrmed by immunoblotting for
VDAC. Next, for assessment of overall ROS levels in BI-1-expressing
cells, the cell-permeable ROS indicator, carboxy-H2-DCFDA, was
used after treatment of the cells with etoposide. Etoposide treatment
strongly induced the generation of ﬂuorescent 2′,7′-dichloroﬂuorescein
(DCF) in control cells. However, BI-1-expressing cells showed low-level
generation of ﬂuorescent DCF (Fig. 3F), implying that BI-1 overexpres-
sion resulted in greater resistance to mitochondria-mediated apoptosis
and ROS generation. To determine the effect of the C-terminal deletion
of BI-1 in BI-1 cellular localization, plasmids containing GFP- or
HA-tagged BI-1 and BI-1 ΔC were prepared and expressed in cells. As
shown in Fig. 3G, the ﬂuorescent images of BI-1 and BI-1 ΔC revealed
a similar localization pattern. Our data are similar to results reported
in the previous study [13], indicating that C-terminal deletion did not
affect the cellular localization of BI-1.
3.3. ERK pathway plays an important role in the anti-apoptotic function
of BI-1
As the MAPKs are a family of proteins that mediate distinct signal-
ing cascades in the regulation of apoptosis, we tested the effect of
MAPK activity on the anti-apoptotic function of BI-1. First, BI-1- or
BI-1 ΔC-overexpressing cells were treated with etoposide and apo-
ptosis induction was monitored at several time points by examination
of PARP cleavage. We were able to detect apparent PARP cleavage in
response to etoposide treatment in HEK 293/pEF HA control cells
and signiﬁcant suppression of PARP cleavage in BI-1-overexpressing
cells (Fig. 4A). As MAPK activation was monitored at several time
points after etoposide treatment, we found that control and BI-1
ΔC-overexpressing cells showed a biphasic response to ERK activa-
tion in a time-dependent manner. ERK phosphorylation peaked 24 h
after etoposide treatment and returned to basal levels after 48 h. On
the other hand, in BI-1-overexpressing cells, ERK was strongly phos-
phorylated even after 24 h of etoposide treatment and its phosphory-
lation increased thereafter over a period of 48 h. However, BI-1
overexpression had little or no inﬂuence on the activation of either
JNK or p38 MAPK. In order to further conﬁrm the direct role of BI-1
expression on etoposide-induced ERK activation, BI-1-speciﬁc
shRNA was introduced into cells overexpressing BI-1 or BI-1 ΔC.
Knockdown of BI-1 expression led to a dramatic increase in
etoposide-induced PARP cleavage in controls, as well as cells overex-
pressing BI-1 and BI-1 ΔC (Fig. 4B). Importantly, knockdown of BI-1
expression resulted in the abolishment of upregulation of ERK activa-
tion in BI-1-overexpressing cells, supporting the notion that BI-1 spe-
ciﬁcally leads to sustained ERK activation. Involvement of sustained
ERK activation in the anti-apoptotic function of BI-1 was alsoFig. 4. Anti-apoptotic effect of BI-1 was closely associated with activation of ERK1/2. (A) Tim
on etoposide stress. Control, BI-1, or BI-1 ΔC cells were treated with 30 μM etoposide for 2
western blotting with anti-PARP, anti-phospho-ERK (p-ERK), anti-total ERK (ERK), anti-ph
(p38) speciﬁc antibody. Actin was used as a loading control. Representative blots from 3
with pSilencer (control) and pSilencer/shBI-1 plasmids. The expression level of BI-1 was det
side (30 μM and 36 h). Equal protein loading was shown by reprobing of the blot with the
analysis in the same cells. (C and D) Transfectant cells were transfected with scramble (−)
Cells were lysed and subjected to western blotting with anti-PARP or anti-p-ERK antibody
(C), and apoptotic cells were assessed by FACS analysis using PI staining (D).conﬁrmed by the use of ERK-speciﬁc siRNA. Suppression of ERK acti-
vation by knockdown of ERK expression by ERK-speciﬁc siRNA led to
the apparent downregulation of ERK phosphorylation and signiﬁcant
abolishment of the anti-apoptotic function of BI-1 expression (Fig. 4C
and D), strongly suggesting that BI-1-induced sustained ERK activa-
tion may be involved in the anti-apoptotic effect of BI-1.
3.4. BI-1-mediated ERK activation leads to downregulation of
ROS-associated apoptosis
As intracellular ROS production was analyzed by incubation of
the cells with H2-DCFDA, we were able to determine that in-
creased ROS production following etoposide treatment was signif-
icantly suppressed by BI-1 overexpression, but not by BI-1 ΔC
expression (Fig. 5A). Pretreatment of cells with the cell-permeant
ROS scavenger, N-acetylcysteine (NAC), led to downregulation of ROS
production and, interestingly, pretreatment with the pharmacological
MEK inhibitor, PD98059, resulted in upregulation of ROS generation
and abolishment of the ROS-suppression effect of BI-1 overexpression,
suggesting an adverse effect of ERK activity on etoposide-induced
ROS production in HEK 293 cells. Next, we analyzed the effects of
NAC pretreatment on ERK activation and PARP cleavage and found
that NAC pretreatment led to the apparent suppression of PARP
cleavage, but did not signiﬁcantly inﬂuence ERK activation (Fig. 5B).
Taken together, our results suggest that BI-1-induced ERK activation
plays a key role in the regulation of intracellular ROS production
and that suppression of ROS production by the BI-1/ERK activation
pathway may be a signiﬁcant factor in the anti-apoptotic effect of
BI-1.
3.5. BI-1 overexpression in BI-1 TG mice results in anti-apoptotic effects,
splenomegaly, and extramedullary megakaryopoiesis
Our data suggest that the ERK pathway executes an important
function in the anti-apoptotic and anti-oxidative effects of BI-1.
To conﬁrm the physiological function of the BI-1/ERK pathway in
vivo, we generated BI-1 TG mice by exogenously expressing HA-
tagged BI-1 on the EF promoter. The BI-1 transgene was transferred
into mice by pronuclear injection and transgene integration was
detected in the genomic DNA of several F0 pups (Fig. 6A). We
were also able to conﬁrm that HA-tagged BI-1 protein was highly
expressed in diverse TG mouse tissues, including heart, lung,
liver, spleen, and testis (Fig. 6B). Next, we prepared MEF cells
from BI-1 TG mice and analyzed the effect of BI-1 overexpression.
First, through RT-PCR and western blot analysis, we conﬁrmed ex-
pression of the BI-1 transgene in BI-1 TG MEF cells (Fig. 6C). Fol-
lowing etoposide treatment, MEF cells from BI-1 TG mice showed
signiﬁcantly lowered PARP cleavage, consistent with the data
obtained with BI-1-expressing HEK 293 cells (Fig. 6D). Compared
with the control MEF cells, we were also able to detect higher
ERK activation and decreased ROS levels in BI-1 TG MEF cells, and
knockdown of BI-1 expression by BI-1-speciﬁc shRNA led to abol-
ishment of BI-1-induced ERK activation and downregulation of in-
tracellular ROS production in MEF cells (Fig. 6D and E). Moreover,
the results obtained in PD98059- or NAC-pretreated BI-1 TG MEF
cells supported our hypothesis that BI-1-induced ERK activation
may play an important role in the regulation of intracellular ROSe-dependent induction of apoptosis and ERK1/2 phosphorylation was analyzed based
4, 36, or 48 h, and protein extracts were prepared. Cellular proteins were analyzed by
ospho-JNK (p-JNK), anti-total JNK (JNK), anti-phospho-p38 (p-p38), or anti-total p38
independent experiments are presented. (B) Stable cells were transiently transfected
ected by western blotting in the cells indicated, with or without treatment with etopo-
actin antibody. Phosphorylation of ERK1/2 and total ERK1/2 was examined by western
or ERK-speciﬁc siRNA (+), and were further cultured with 30 μM etoposide for 36 h.
. The membrane was sequentially reprobed with anti-ERK or anti-actin, as indicated
Fig. 5. BI-1 overexpression led to suppression of etoposide-induced ROS generation, and was dependent on ERK activation. Cells were cultured in the presence or absence of etoposide
(30 μM), NAC (1 mM), and PD98059 (20 μM) for 24 h. NAC and PD98059were added at the beginning of the experiment. (A) The level of intracellular ROS in stable transfectant cells was
visualized by DCF staining. ROS levels were visualized by ﬂuorescence of the dye H2-DCFDA (10 μM) and quantiﬁedwith FACScan. The results shown are representative of 3 independent
experiments performed in triplicate. (B) The cell lysates were subjected to western blotting with antibody against p-ERK, total ERK, actin, or PARP.
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in vivo effect of BI-1 overexpression in BI-1 TG mice and observed
that the spleen of BI-1 TG mice was enlarged, with an average
weight of approximately 0.2 g, which were 3–4 times heavier
than that of control mice (Fig. 7A). Morphological and histochemi-
cal analysis of the enlarged spleens indicated that the splenomega-
ly was accompanied by disruption of the normal architecture of
spleen pulp, resulting in loss of the boundaries (marginal zones)
that separate white pulp from red pulp (Fig. 7B). Interestingly, we
detected a signiﬁcant increase in megakaryocytes in the spleen
from BI-1 TG mice and, in fact, we could observe a consistent in-
crease in the level of ERK phosphorylation in the BI-1 TG spleen tis-
sue (Fig. 7C). Moreover, from the analysis of splenocytes prepared
from BI-1 TG mice, we could conﬁrm that BI-1 overexpression
plays an important role in etoposide-induced apoptosis of spleno-
cytes, which is apparently modulated by a BI-1-mediated ERK path-
way (Fig. 7D and E), suggesting that BI-1-induced ERK activation
may be a signiﬁcant signaling module in the anti-apoptotic and im-
mune response-regulating functions of BI-1.
4. Discussion
The apoptotic process is regulated by a variety of diverse pro-
teins, including Bcl-2 and caspase family proteins, and an under-
standing of their functions is important for the elucidation of the
regulatory mechanisms of many apoptosis-related diseases [1,2].
The BI-1 family proteins containing BI-1-like transmembrane do-
mains were expected to play an important role in apoptosis.
Some of these proteins have been reported to interact with Bcl-2family proteins and have cytoprotective effects, but their precise
role and their regulatory mechanisms remain to be determined
[30–32]. In order to gain insight into the signiﬁcance of BI-1 family
proteins in apoptosis, we ﬁrst investigated the structure of several
BI-1 family proteins, including FAIM2, TMBIM4, and GHITM. Bioin-
formatic analysis revealed that BI-1 family proteins share a func-
tionally unknown transmembrane protein domain (UPF0005
motif), with variable N-terminal and C-terminal regions and 6 or
7 transmembrane passages (Fig. 1). These morphological resem-
blances or variations between BI-1 family proteins may determine
their cellular functions. Previous studies have already shown that
FAIM2 could protect cells against Fas-induced apoptosis, and
TMBIM4 was also shown to inhibit both intrinsic and extrinsic
pathway-mediated apoptosis [33,34]. Moreover, GHITM has been
reported to play a role in the maintenance of mitochondrial mor-
phology and delay of apoptotic release of cytochrome C [35].
Studies have also been carried out to determine whether BI-1
plays a cytoprotective role against ER stress, which was induced
by pharmacological inducers such as tunicamycin and thapsigargin
[19]. These results suggest that BI-1 family proteins may play a
central role in anti-apoptotic regulation in animals. Deﬁciency of
BI-1 in mice has resulted in elevated levels of ER stress markers
and the activation of stress kinases, such as JNK and p38 MAPK
[21]. In this study, we compared the anti-apoptotic properties of
BI-1 family proteins against stress-associated or mitochondria-
mediated apoptosis and found that BI-1 has a strong anti-
apoptotic effect on etoposide-induced apoptosis in HEK 293 cells
(Figs. 2 and 3). Generally, the MAPK pathway is important in the
regulation of various cellular functions, including proliferation,
Fig. 6.MEF cells fromBI-1 TGmice apparently revealed ERK activation-dependent anti-apoptosis. (A) BI-1 transgene integrations in genomic DNA (10 μg) of representative F0 pups (TG-1
to TG-4) and background strain C57BL/6N (Control) were analyzed via genomic DNA-PCR analysis. We used speciﬁc primer pairs containing the BI-1-speciﬁc coding sequence (reverse
primer) alongwith the EFpromoter sequence (forwardprimer). Tail biopsieswere used for genomicDNA-PCR analysis (lower panel).M:DNA sizemarker. (B) BI-1 expression levelswere
shown in diverse tissues of 6-month-old controls (C) or BI-1 transgenic (BI) mice (He: Heart, Lu: Lung, Li: Liver, Sp: Spleen, Te: Testis, St: Stomach). (C) Using a speciﬁc BI-1 primer, we
tested expression of BI-1mRNA in eachMEF cell from BI-1 TGmice and control mice (left panel). BI-1 expression was analyzed bywestern blotting using HA antibody in control and BI-1
TGMEF cells (right panel) (P/C: Positive control, normalMEF cells transiently transfectedwith BI-1). (D and E) EachMEF cell linewas treatedwith etoposide in the absence or presence of
PD98059, NAC, or BI-1-speciﬁc shRNA for 36 h. Cells were lysed, and the total lysates were subjected to immunoblotting for detection of phosphorylated ERK (p-ERK), total ERK (ERK),
PARP, or actin (D). After treatment of etoposide for 24 h, cells were stained with DCF and analyzed using FACS analysis (E).
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In mammalian cells, the MAPK family has been divided into 3
groups, making up the ERK, JNK, and p38 pathways. Previous re-
ports have shown that BI-1 regulates ER stress markers, including
JNK phosphorylation in cells overexpressing or deﬁcient in BI-1
[36,37]. However, in this study, although levels of JNK and p38
phosphorylation were not apparently changed on BI-1 overexpres-
sion, BI-1 overexpression led to signiﬁcant inhibition of stress-
induced apoptosis via activation of the ERK pathway. Moreover,
we attempted to reveal the molecular mechanism of BI-1-
mediated anti-apoptosis using cells and transgenic (TG) mice over-
expressing BI-1. In BI-1 TG MEF cells, knockdown of BI-1 expres-
sion by BI-1-speciﬁc shRNA led to enhanced PARP cleavage,
abolishment of BI-1-induced ERK activation and downregulation
of intracellular ROS production in MEF (Fig. 6C). However, BI-1
shRNA-induced inhibition of BI-1 expression did not result in asigniﬁcant induction in the PARP cleavage and ROS production of
normal MEF cells. We think that BI-1-knockdown MEFs displayed
normal sensitivity to etoposide-induced apoptosis. Our result was
similar with other previous study [19] showing that BI-1-deﬁcient
MEF showed no signiﬁcant difference in apoptotic ratio compared
with wild-type MEF. The causes of these results certainly not yet
well understood, so we need further study.
Interestingly, TG mice overexpressing BI-1 showed higher ERK ac-
tivation and spontaneously developed splenomegaly and megakaryo-
poiesis, which is a similar phenotype to that of certain transgenic
mice in which the ERK pathway has been upregulated or apoptosis
blocked [38–43]. These observations indicate that BI-1 overexpres-
sion may modulate the apoptotic signaling pathway and autoimmu-
nity through regulation of ERK activation. Consistently, previous
studies also reported the involvement of ERK1/2 activation in the re-
sistance to apoptosis in response to diverse apoptotic stimuli [44,45].
Fig. 7. BI-1 overexpression leads to splenomegaly and extramedullary megakaryopoiesis. (A) BI-1 TG mice were larger than control mice and displayed splenomegaly. Pictures are
representative of 3 mice analyzed for each group. The histogram shows mean wet weight of spleens freshly dissected from adult control and BI-1 TG mice. (B) The spleens from
control and BI-1 TG mice were ﬁxed, embedded in parafﬁn, sectioned, stained with H&E, and examined by light microscopy. Megakaryocytes are indicated by black arrowheads.
(C) Control and BI-1 spleen tissue was lysed, and an equal amount of cell lysate was blotted for p-ERK, ERK, and actin. Parafﬁn-embedded spleen tissues from each mouse were
probed with anti-p-ERK antibody. Findings replicated in independent preparations of six pairs of mice. (D) BI-1 expression levels were observed in control and BI-1 TG splenocytes.
(E) Control and BI-1 TG splenocytes treated with etoposide in the absence or presence of BI-1 shRNA, or ERK siRNA. Apoptotic cells were detected by PI staining using FACS analysis.
All data are expressed as the means±SE of values obtained in 4 separate experiments.
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tion during etoposide treatment, consistent with previous ﬁndings
demonstrating the importance of sustained ERK1/2 activation in cell
survival [46,47].
The mechanism by which BI-1 regulates ERK activation remains
unknown. ERK1/2 regulates diverse cellular processes, including cell
cycle progression, proliferation, and differentiation. Moreover, it is
implicated in immune system development, homeostasis, and tissue
development. Complex upstream cascades, including numerous
GTP-binding proteins, kinases, and phosphatases, have been reported
to inﬂuence ERK activation. A previous study reported that the C ter-
minus of plant BI-1 interacts with calmodulin, which contains a
calcium-binding domain that regulates diverse intracellular signalpathways by activation of calcium/calmodulin-dependent protein ki-
nase (CaMK) [48], and ERK activation by CaMKII was also demon-
strated through direct binding of the protein with MEK1 or Raf-1
[49,50]. On the basis of these reports, research into the exact mecha-
nism for the involvement of BI-1 in ERK activation is underway. In ad-
dition, several reports have suggested that BI-1 homolog proteins
could protect yeast and plant cells from oxidative stress [13–15,28].
In relation to this ﬁnding, we found that ERK activation by BI-1 over-
expression led to a reduction in intracellular ROS levels (Figs. 5 and
6). ROS are known to be generated by several pathways and produc-
tion of ROS results in cell damage, aging, and apoptosis [51,52]. Mito-
chondria are the major sites of ROS production and mitochondrial
ROS leads to oxidative stress with enhanced activity of the
887J.-H. Kim et al. / Biochimica et Biophysica Acta 1823 (2012) 876–888antioxidant defense system [53,54]. Anti-apoptotic Bcl-2 protein is
one of the defense systems associated with defense against oxidants
and a change in the cellular ROS level [55,56]. According to several
previous studies, ROS could be an important mediator of apoptosis
and MAPK regulation [57]. Consistent with these ﬁndings, our
data showed that ROS regulation may be dependent upon BI-1-
dependent ERK activation.
Importantly, our results suggest that BI-1 may affect the autoim-
mune response, as indicated by the results in BI-1 TG mice, showing
that overexpression of BI-1 led to abnormal spleen morphology,
splenomegaly, and megakaryocytes (Fig. 7A and B). Many scientists
have suggested that diverse mechanisms are essential for autoim-
mune responses and that many determinants could induce these re-
sponses through abnormal regulation of the apoptosis-regulating
mechanisms [58]. Apoptosis-regulating proteins have been reported
to be involved in numerous signaling pathways that appear to be nec-
essary for the maintenance of tolerance and thus for healthy immune
systems [59]. Inefﬁcient apoptosis may lead to a failure to delete self-
reactive lymphocytes and expansion of immature and functionally
defective lymphocytes. In the case of Bax deﬁciency or Bcl-2 overex-
pression, an imbalance of pro- or anti-apoptotic proteins has been
reported to alter lymphocyte development [41] or lymphocytic leuke-
mia [42]. A crucial role in the autoimmune response has been sug-
gested for the MAPK cascade [60–62] and recent reports have stated
that ERK could be involved in lymphoproliferative disease [39] and
polycythemia vera-like disease [40]. Some papers have suggested
that the ERK signaling pathway plays an important role in diverse au-
toimmune responses, including T-cell or B-cell activation and lym-
phoproliferation [39,63–66]. Therefore, further studies are required
to determine whether the autoimmune response is associated with
regulation of apoptosis and ERK activation by BI-1 overexpression.
Consequently, our results demonstrate that BI-1 expression may in-
duce sustained ERK activation and reduce ROS production, leading
to suppression of autoimmune response-related apoptosis.
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